Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study

• Main Authors: Keigo Koda (Author), Yasunori Enomoto (Author), Yoichiro Aoshima (Author), Yusuke Amano (Author), Shinpei Kato (Author), Hirotsugu Hasegawa (Author), Takashi Matsui (Author), Koshi Yokomura (Author), Eisuke Mochizuki (Author), Shun Matsuura (Author), Naoki Koshimizu (Author), Meiko Morita (Author), Suguru Kojima (Author), Ayano Watanabe (Author), Yoshiyuki Oyama (Author), Masaki Ikeda (Author), Hideki Kusagaya (Author), Tomohiro Uto (Author), Jun Sato (Author), Shiro Imokawa (Author), Masato Kono (Author), Dai Hashimoto (Author), Yosuke Kamiya (Author), Mikio Toyoshima (Author), Kazuhiro Asada (Author), Masako Morita (Author), Masashi Mikamo (Author), Hideki Yasui (Author), Hironao Hozumi (Author), Masato Karayama (Author), Yuzo Suzuki (Author), Kazuki Furuhashi (Author), Tomoyuki Fujisawa (Author), Noriyuki Enomoto (Author), Yutaro Nakamura (Author), Naoki Inui (Author), Takafumi Suda (Author)
• Format: Book
• Published: SAGE Publishing, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Although recent advances in chemotherapy for lung cancer are remarkable, most clinical trials have excluded patients with interstitial lung disease (ILD) due to the concern of developing acute exacerbation (AE) of ILD. Hence, accumulating original evidence of cancer treatment for this...